Current Treatment Options in Oncology

Papers
(The H4-Index of Current Treatment Options in Oncology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers110
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead77
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer75
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia74
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes61
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma55
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer55
An Update on Temporal Bone Paragangliomas54
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies53
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)45
The Role of Nursing in the Delivery of Cardio-Oncology44
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect44
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?39
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?39
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T37
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer36
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors34
Management of Fatigue in Patients with Advanced Cancer34
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma33
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers30
Small Cell Lung Cancer—An Update on Chemotherapy Resistance30
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?29
Approach to Localized Squamous Cell Cancer of the Esophagus29
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer28
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements28
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities28
Advances in Targeted Therapy for Metastatic Prostate Cancer26
Regorafenib for the Treatment of Sarcoma26
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management26
0.044183015823364